Retour sur lavenir.net
   WDP 21.880 € (+0,64 %)     TUBIZE-FIN 215.000 € (+0,09 %)     UCB 248.400 € (-0,12 %)     MELEXIS 76.750 € (+3,72 %)     AEDIFICA 69.350 € (+0,29 %)     ONTEX GROUP 2.290 € (-0,43 %)     KBC 119.550 € (+1,53 %)     SOLVAY 26.040 € (+0,54 %)     ARGENX SE 787.600 € (-1,53 %)     UMICORE 20.120 € (+1,82 %)     LOTUS BAKERIES 11 180.000 € (-0,53 %)     AB INBEV 69.280 € (-0,63 %)     SYENSQO 65.400 € (+1,00 %)     GBL 78.200 € (+0,13 %)     FAGRON 23.850 € (+0,21 %)     RETAIL ESTATES 68.300 € (+0,44 %)     KBC ANCORA 83.100 € (+1,59 %)     COLRUYT 36.500 € (-0,05 %)     MONTEA 66.300 € (+0,45 %)     DEME GROUP 170.400 € (+1,43 %)     XIOR 27.300 € (+0,74 %)     AGEAS 71.150 € (+0,35 %)     NYXOAH 1.516 € (+0,53 %)     DECEUNINCK 2.240 € (+0,45 %)     ELIA GROUP 136.500 € (+0,15 %)     SOFINA 225.400 € (+0,45 %)     ACKERMANS V.HAAREN 270.000 € (+1,28 %)     RECTICEL 11.100 € (+0,54 %)     CIE BOIS SAUVAGE 301.000 € (+0,33 %)     PROXIMUS 5.840 € (-0,51 %)     SHURGARD 26.300 € (+1,15 %)     D'IETEREN GROUP 171.000 € (+0,18 %)     ONWARD MEDICAL 2.530 € (+3,48 %)     AZELIS GROUP 9.900 € (-0,50 %)     CARE PROPERTY INV. 12.580 € (+0,48 %)     IBA 16.600 € (+0,61 %)     BARCO 8.455 € (+0,77 %)     VASTNED 29.500 € (+0,51 %)     BPOST 1.610 € (+0,63 %)     CMB.TECH 13.600 € (-0,15 %)     VGP 83.100 € (+1,59 %)     TITAN S.A. 50.200 € (+1,50 %)     HOME INVEST BE. 19.080 € (+0,74 %)     ECONOCOM GROUP 1.435 € (+0,35 %)     EKOPAK 3.470 € (+0,14 %)     BEKAERT 40.050 € (+1,52 %)     VAN DE VELDE 29.900 € (0,00 %)     QUESTFOR GR-PRICAF 2.961 € (-0,95 %)     WAREHOUSES ESTATES 39.900 € (-0,25 %)     BQUE NAT. BELGIQUE 369.000 € (-0,27 %)     VIOHALCO 17.940 € (+0,11 %)     JENSEN-GROUP 83.000 € (+0,97 %)     SIPEF 91.200 € (+1,11 %)     CFE 13.000 € (+1,96 %)     BREDERODE 103.600 € (0,00 %)     QRF 10.200 € (0,00 %)     HYLORIS 4.400 € (-0,23 %)     BIOTALYS 3.030 € (-0,16 %)     ATENOR 1.690 € (+2,42 %)     OXURION 0.003 € (+7,14 %)  
   VIRIDIEN 83.150 € (+1,71 %)     CVC CAPITAL 12.890 € (-1,23 %)     EXOSENS 59.850 € (+0,93 %)     EMEIS 14.030 € (-0,07 %)     LLAMA GROUP 0.397 € (-2,93 %)     PULLUP ENTERTAIN 7.500 € (+2,46 %)     OPMOBILITY 13.580 € (+0,37 %)     EDP 4.495 € (+0,27 %)     BNP PARIBAS ACT.A 99.575 € (+1,33 %)     SANOFI 75.030 € (-0,45 %)     ACCOR 48.530 € (+0,71 %)     ABIONYX PHARMA 1.890 € (+1,94 %)     VINCI 118.400 € (+0,13 %)     KAUFMAN ET BROAD 24.000 € (-0,83 %)     KPN KON 4.242 € (-0,75 %)     STMICROELECTRONICS 60.560 € (+3,54 %)     KERING 245.800 € (+2,57 %)     BIOMERIEUX 68.400 € (-1,08 %)     BOUYGUES 46.280 € (+0,26 %)     SOCIETE GENERALE 72.960 € (+2,33 %)     AIRBUS 198.740 € (+0,70 %)     THALES 231.900 € (-0,77 %)     CSG 14.000 € (0,00 %)     REXEL 37.440 € (+1,49 %)     SCHNEIDER ELECTRIC 268.500 € (+1,78 %)     UNILEVER 53.950 € (-0,92 %)     J.MARTINS,SGPS 16.160 € (-0,12 %)     ASML HOLDING 1 567.400 € (+2,51 %)     SHELL PLC 36.090 € (-0,17 %)     SOITEC 105.200 € (+6,98 %)     AIR FRANCE -KLM 12.695 € (-1,13 %)     PUBLICIS GROUPE SA 84.800 € (-0,42 %)     FDJ UNITED 22.820 € (+0,44 %)     UBISOFT ENTERTAIN 6.152 € (+5,16 %)     VIVENDI SE 1.959 € (+0,88 %)     2CRSI 32.900 € (+1,48 %)     MEDIANTECHNOLOGIES 4.610 € (+0,22 %)     ASM INTERNATIONAL 916.200 € (+2,97 %)     CAPGEMINI 88.520 € (-2,62 %)     GENFIT 13.420 € (-2,47 %)     PHARMING GROUP 1.264 € (+0,56 %)     WOLTERS KLUWER 61.900 € (+4,88 %)     DASSAULT SYSTEMES 17.970 € (+0,03 %)     CREDIT AGRICOLE 17.415 € (+1,25 %)     VALEO 12.120 € (-0,49 %)     DANONE 72.680 € (-0,68 %)     BE SEMICONDUCTOR 249.000 € (+3,19 %)     UNIBAIL-RODAMCO-WE 101.650 € (+0,89 %)     ADYEN 829.200 € (-0,11 %)     EIFFAGE 119.700 € (+0,55 %)     TOTALENERGIES 69.150 € (-0,29 %)     B.COM.PORTUGUES 1.023 € (0,00 %)     PROSUS 40.315 € (-0,20 %)     ARKEMA 54.750 € (+0,18 %)     ORANGE 15.880 € (-0,44 %)     VALERIO TX 0.434 € (-4,62 %)     LVMH 488.200 € (+0,68 %)     NOS, SGPS 4.878 € (0,00 %)     RELX 28.420 € (+1,00 %)     CM.COM 7.250 € (+1,83 %)  
News Réglementées
11/04/2023 13:31

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

The Vanguard Group, Inc. ( IRSH)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

11-Apr-2023 / 12:31 GMT/BST


Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

  1.         Full name of discloser

The Vanguard Group, Inc.

  1.         Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

  1.         Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

Horizon Therapeutics plc

  1.         If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

 

  1.         Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

06 April 2023

  1.           In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security
(Note 3)

US$0.0001 ordinary shares

 

Interests

Short positions

Number

%

Number

%

  1. Relevant securities owned and/or controlled

21,571,193

9.43%

 

 

  1. Cash-settled derivatives

 

 

 

 

  1. Stock-settled derivatives (including options) and agreements to purchase/ sell

 

 

 

 

Total

21,571,193

9.43%

 

 

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit
(Note 5)

US$0.0001 ordinary shares

Purchase

6,868

108.71 USD

US$0.0001 ordinary shares

Purchase

2,796

108.72 USD

US$0.0001 ordinary shares

Sale

207

108.72 USD

 

 

 

Ap29

 

(b) Cash-settled derivative transactions

 

Class of
relevant
security

Product
description
e.g. CFD

Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of
reference
securities
(Note 6)

Price
per unit
(Note 5)

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of
relevant
security

Product
description e.g. call
option

Writing, purchasing, selling, varying
etc.

Number
of
securities
to which
option
relates
(Note 6)

Exercise
price per
unit

Type
e.g.
American,
European
etc.

Expiry
date

Option
money
paid/
received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of
relevant
security

Product
description
e.g. call
option

Exercising/
exercised
against

Number of
securities

Exercise
price per
unit
(Note 5)

  

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of
relevant
security

Nature of dealing
e.g. subscription,
conversion, exercise

Details

Price per unit (if
applicable)
(Note 5)

 Not Applicable

 

 

 

 

Ap30

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 none

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière